Revvity Price to Sales Ratio 2010-2024 | RVTY
Revvity P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2024-06-25 | 104.64 | 4.78 | |
2024-03-31 | 104.93 | $21.89 | 4.79 |
2023-12-31 | 109.16 | $21.97 | 4.97 |
2023-09-30 | 110.47 | $22.25 | 4.96 |
2023-06-30 | 118.48 | $22.48 | 5.27 |
2023-03-31 | 132.84 | $23.90 | 5.56 |
2022-12-31 | 139.71 | $26.17 | 5.34 |
2022-09-30 | 119.82 | $24.00 | 4.99 |
2022-06-30 | 141.55 | $25.86 | 5.47 |
2022-03-31 | 173.57 | $29.71 | 5.84 |
2021-12-31 | 199.95 | $33.73 | 5.93 |
2021-09-30 | 172.27 | $32.14 | 5.36 |
2021-06-30 | 153.43 | $33.23 | 4.62 |
2021-03-31 | 127.41 | $29.56 | 4.31 |
2020-12-31 | 142.45 | $23.78 | 5.99 |
2020-09-30 | 124.52 | $28.91 | 4.31 |
2020-06-30 | 97.25 | $26.66 | 3.65 |
2020-03-31 | 74.57 | $25.88 | 2.88 |
2019-12-31 | 96.12 | $26.82 | 3.58 |
2019-09-30 | 84.24 | $25.63 | 3.29 |
2019-06-30 | 95.22 | $25.60 | 3.72 |
2018-12-31 | 77.51 | $24.91 | 3.11 |
2018-09-30 | 95.91 | $23.92 | 4.01 |
2018-06-30 | 72.14 | $23.71 | 3.04 |
2018-03-31 | 74.53 | $22.40 | 3.33 |
2017-12-31 | 71.90 | $21.55 | 3.34 |
2019-03-31 | 95.17 | $20.43 | 4.66 |
2017-09-30 | 67.76 | $19.73 | 3.43 |
2017-06-30 | 66.87 | $19.41 | 3.44 |
2017-03-31 | 56.91 | $19.36 | 2.94 |
2016-12-31 | 51.05 | $19.17 | 2.66 |
2016-09-30 | 54.85 | $18.01 | 3.05 |
2016-06-30 | 51.18 | $18.30 | 2.80 |
2016-03-31 | 48.23 | $18.38 | 2.62 |
2015-12-31 | 52.15 | $18.54 | 2.81 |
2015-09-30 | 44.68 | $18.44 | 2.42 |
2015-06-30 | 51.11 | $18.24 | 2.80 |
2015-03-31 | 49.58 | $18.17 | 2.73 |
2014-12-31 | 42.33 | $18.19 | 2.33 |
2014-09-30 | 42.13 | $19.50 | 2.16 |
2014-06-30 | 45.19 | $19.35 | 2.34 |
2014-03-31 | 43.40 | $19.27 | 2.25 |
2013-12-31 | 39.65 | $19.01 | 2.09 |
2013-09-30 | 36.23 | $18.72 | 1.94 |
2013-06-30 | 31.13 | $18.53 | 1.68 |
2013-03-31 | 32.16 | $18.29 | 1.76 |
2012-12-31 | 30.28 | $18.62 | 1.63 |
2012-09-30 | 28.05 | $17.72 | 1.58 |
2012-06-30 | 24.49 | $17.50 | 1.40 |
2011-12-31 | 18.87 | $16.83 | 1.12 |
2011-09-30 | 18.06 | $16.05 | 1.13 |
2011-06-30 | 25.23 | $16.54 | 1.53 |
2011-03-31 | 24.57 | $15.87 | 1.55 |
2010-12-31 | 24.08 | $15.55 | 1.55 |
2012-03-31 | 26.18 | $14.92 | 1.75 |
2010-09-30 | 21.52 | $13.02 | 1.65 |
2010-06-30 | 19.15 | $12.71 | 1.51 |
2010-03-31 | 22.08 | $12.92 | 1.71 |
2009-12-31 | 18.96 | $13.31 | 1.42 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.912B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $124.411B | 15.61 |
Cencora (COR) | United States | $47.535B | 18.53 |
ICON (ICLR) | Ireland | $26.024B | 24.57 |
DiDi Global (DIDIY) | China | $21.386B | 0.00 |
Avantor (AVTR) | United States | $14.991B | 22.07 |
CochLear (CHEOY) | Australia | $14.406B | 0.00 |
Natera (NTRA) | United States | $13.674B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.625B | 41.54 |
Viatris (VTRS) | United States | $12.276B | 3.67 |
Charles River Laboratories (CRL) | United States | $10.631B | 20.35 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $9.816B | 0.00 |
Solventum (SOLV) | United States | $8.851B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.578B | 0.00 |
HealthEquity (HQY) | United States | $7.199B | 46.22 |
Organon (OGN) | United States | $5.347B | 5.07 |
Bausch + Lomb (BLCO) | Canada | $5.239B | 20.97 |
Doximity (DOCS) | United States | $5.140B | 36.00 |
PACS (PACS) | United States | $4.365B | 0.00 |
Life Times (LTH) | United States | $3.678B | 38.54 |
Sotera Health (SHC) | United States | $3.377B | 16.57 |
GoodRx Holdings (GDRX) | United States | $2.934B | 111.71 |
Surgery Partners (SGRY) | United States | $2.928B | 26.79 |
Agilon Health (AGL) | United States | $2.583B | 0.00 |
Progyny (PGNY) | United States | $2.525B | 43.47 |
AMN Healthcare Services Inc (AMN) | United States | $2.023B | 8.02 |
NovoCure (NVCR) | Jersey | $1.941B | 0.00 |
Premier (PINC) | United States | $1.936B | 8.28 |
BrightSpring Health Services (BTSG) | United States | $1.826B | 0.00 |
Teladoc Health (TDOC) | United States | $1.653B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
Alignment Healthcare (ALHC) | United States | $1.400B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.225B | 0.00 | |
CareDx (CDNA) | United States | $0.761B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.712B | 0.00 |
Embecta (EMBC) | United States | $0.704B | 4.79 |
Pediatrix Medical (MD) | United States | $0.644B | 6.83 |
InnovAge Holding (INNV) | United States | $0.634B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.599B | 0.00 |
Sharecare (SHCR) | United States | $0.500B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
Enhabit (EHAB) | United States | $0.422B | 42.05 |
COMPASS Pathways (CMPS) | United Kingdom | $0.415B | 0.00 |
ModivCare (MODV) | United States | $0.362B | 6.77 |
Sonida Senior Living (SNDA) | United States | $0.324B | 0.00 |
DocGo (DCGO) | United States | $0.305B | 16.67 |
LifeMD (LFMD) | United States | $0.282B | 0.00 |
MultiPlan (MPLN) | United States | $0.231B | 0.00 |
Beauty Health (SKIN) | United States | $0.225B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.196B | 0.00 |
Sera Prognostics (SERA) | United States | $0.183B | 0.00 |
Biodesix (BDSX) | United States | $0.181B | 0.00 |
So-Young (SY) | China | $0.107B | 51.50 |
Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
NeueHealth (NEUE) | United States | $0.043B | 5.74 |
Co-Diagnostics (CODX) | United States | $0.042B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
Oncology Institute (TOI) | United States | $0.032B | 0.00 |
Nutex Health (NUTX) | United States | $0.028B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.020B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.019B | 0.00 |
KindlyMD (KDLY) | $0.018B | 0.00 | |
BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
ISpecimen (ISPC) | United States | $0.005B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
DermTech (DMTK) | United States | $0.004B | 0.00 |
OpGen (OPGN) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Assure Holdings (IONM) | United States | $0.002B | 0.00 |